Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC M&A Activity 2021

Jan 15, 2021

5250_rns_2021-01-15_3ac04ad7-d2a8-4ee8-b56a-6381ed57dbf3.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

FORM 8.3

Amendment to Purchase and Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 12 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,704,722 2.10% 683,032 0.53%
(2) Derivatives (other than options):
354,221 0.27% 535,343 0.42%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
(4) TOTAL:
3,058,943 2.37% 1,218,375 0.95%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 201.3600 USD
Purchase 1 201.3100 USD
Purchase 1 200.0500 USD
Purchase 77 199.5976 USD
Purchase 100 202.0150 USD
Purchase 100 201.9900 USD
Purchase 200 198.4800 USD
Purchase 200 199.9850 USD
Purchase 211 199.6783 USD
Purchase 300 201.6433 USD
Purchase 600 201.3316 USD
Purchase 600 200.7525 USD
Purchase 700 201.3428 USD
Purchase 750 200.3313 USD
Purchase 800 201.1281 USD
Purchase 1,083 200.9922 USD
Purchase 1,119 199.5001 USD
Purchase 1,613 200.9469 USD
Purchase 2,711 199.5800 USD
Purchase 2,727 200.2109 USD
Purchase 4,536 200.0027 USD
Purchase 12,783 199.9758 USD
Purchase 13,254 200.7304 USD
Purchase 17,419 200.8755 USD
Purchase 18,137 200.6952 USD
Purchase 18,176 199.9500 USD
Purchase 84,681 200.6247 USD
Sale 2 199.9450 USD
Sale 2 201.3100 USD
Sale 7 200.2142 USD
Sale 50 200.5100 USD
Sale 100 201.3500 USD
Sale 205 201.4385 USD
Sale 278 198.4800 USD
Sale 300 201.5566 USD
Sale 300 201.6853 USD
Sale 423 201.0195 USD
Sale 905 199.5399 USD
Sale 1,154 201.5603 USD
Sale 1,217 200.3603 USD
Sale 1,497 200.3569 USD
Sale 1,690 200.4830 USD
Sale 1,803 199.9606 USD
Sale 2,301 200.0779 USD
Sale 2,592 200.2809 USD
Sale 3,019 200.6431 USD
Sale 4,114 200.4885 USD
Sale 4,879 199.9775 USD
Sale 5,312 199.5800 USD
Sale 7,175 200.6253 USD
Sale 9,330 200.4386 USD
Sale 9,359 200.8751 USD
Sale 9,507 199.5595 USD
Sale 15,142 200.7002 USD
Sale 15,885 199.9500 USD
Sale 16,514 200.8386 USD
Sale 20,000 200.8158 USD
Sale 23,153 200.9257 USD
Sale 25,031 200.4992 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 15 Jan 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

View source version on businesswire.com: https://www.businesswire.com/news/home/20210114006110/en/

BARCLAYS PLC